Congress Unplugged presents Iya Khalil, Executive VP and co-founder of GNS Healthcare.
Iya Khalil oversees the application of the companyâ€™s simulation technology to critical challenges in the healthcare industry.
A frequent speaker at industry events and conferences, she has extensive experience in reverse engineering and forward simulations of large-scale genetic and biochemical networks. Iya is an inventor on a number of pending patents and has published multiple articles on in silico technologies applied to drug discovery and development. Prior to joining GNS Healthcare, she worked at Cornell University, University of Washington, and Abbott Labs. Iya holds a B.S. in physics from the University of Washington and a Ph.D. in physics from Cornell University.
Application of engineering principles and equipment to biology and medicine. It includes the development and fabrication of life-support systems for underwater and space exploration, devices for medical treatment (seedialysis, prosthesis), and instruments for monitoring biological processes. Development has been particularly rapid in the area of artificial organs, which culminated in the implantation of an artificial heart into a human being in 1982. Bioengineers also develop equipment that enables humans to maintain body functions in hostile environments, such as the space suits worn by astronauts during extravehicular maneuvers.